Abstract
Objective: To estimate plasma concentrations-time profiles of Sulfamethoxazole (SMZ) and Trimethoprim (TMP) from fixed-dose combination formulations through in vitro data of dissolution media of physiological relevance and a convolution model.
Methods: Dissolution profiles of SMZ/TMP tablets (400/80 mg) were obtained with USP paddle apparatus at 100 rpm and 900 ml of 0.1 N HCl, pH 4.5 acetate buffer, and pH 6.8 phosphate buffer. The reference drug product and two generic formulations were tested. Drugs were quantified by a derivative method. Dissolution profiles were compared with model-dependent and independent methods. SMZ/TMP plasma levels were simulated with dissolution data and published in vivo information. Percent of prediction error (PE) for peak plasma concentration (Cmax) and area under the curve from zero time to infinity (AUC0-inf) at each condition were calculated.
Results: In all used conditions, similar dissolution profiles were found excepting for TMP at pH 1.2 (f2<50). The in vitro release performance for reference and generic formulations was explained by the Weibull function only for SMZ at pH 6.8 and TMP at pH 4.5. Values of PE>19% for both generic formulations were found with TMP at pH 1.2.
Conclusion: Significant differences in TMP dissolution profiles of generic formulations at pH 1.2 reflect the subsequent differences found in predicted Cmax and AUC0-inf.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference31 articles.
1. Masters PA, O’Bryan TA, Zurlo J, Miller DQ, Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med. 2003;163(4):402-10. doi: 10.1001/archinte.163.4.402, PMID 12588198.
2. Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm. 2004;58(2):265-78. doi: 10.1016/j.ejpb.2004.03.001, PMID 15296954.
3. United States Pharmacopeia. USP 44. NF 39. The United States of America Pharmacopeial Convention. Rockville, MD: Inc; 2021.
4. Uddin R, Saffoon N, Sutradhar B. Dissolution and dissolution apparatus: a review. Int J Curr Biomed Pharm Res. 2011;1(4):201-7.
5. Fuerte V, Maldonado M, Rees GD. The multicomponent automated dissolution system: an alternative in the development and pharmaceutical analysis of generic polydrugs. J Pharm Biomed Anal. 1999;21(2):267-72. doi: 10.1016/s0731-7085(99)00122-3, PMID 10703981.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献